The ITA asserts an apparent ADRV against Bulgarian weightlifter Yunder Beytula
THE INTERNATIONAL TESTING AGENCY (ITA) REPORTS THAT A SAMPLE COLLECTED FROM BULGARIAN WEIGHTLIFTER YUNDER BEYTULA HAS RETURNED AN ADVERSE ANALYTICAL FINDING (AAF) FOR HUMAN GROWTH HORMONES (HGH) (S2. PEPTIDE HORMONES, GROWTH FACTORS).
The ITA reports that a sample collected from Mr. Beytula during an out-of-competition testing mission on 1 July 2021 carried out in Bulgaria on behalf of the International Weightlifting Federation (IWF) has returned an Adverse Analytical Finding for prohibited Human Growth Hormones.
The athlete has been notified of the case and the provisional suspension imposed against him on 10 June 2021 by the ITA based on an incident that occurred during an Out-Of-Competition testing mission on 29 December 2020 (more information: here) is maintained until the resolution of the matter. Mr. Beytula has the right to request the analysis of the B-sample.
If confirmed, this will potentially be the athlete’s third ADRV as Mr Beytula was previously sanctioned with a period of ineligibility from 11 October 2013 until 11 October 2015 for the presence of prohibited anabolic steroids in a sample collected from him on 25 September 2013 and was charged by the ITA with additional anti-doping rule violations on 10 June 2021 as mentioned above.
Should he not accept the consequences provided for under the IWF ADR, he will have the right to ask for a hearing.
Pursuant to the IWF’s delegation of its anti-doping program to the ITA, the prosecution of this case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments during the ongoing proceeding.
The original article can be found here.
